• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

良性前列腺增生症患者下尿路症状与血清性激素水平的关系。

Relationship between lower urinary tract symptoms and serum levels of sex hormones in men with symptomatic benign prostatic hyperplasia.

机构信息

Department of Urology, University of Catania, Catania, Italy.

出版信息

BJU Int. 2010 Dec;106(11):1700-3. doi: 10.1111/j.1464-410X.2010.09459.x.

DOI:10.1111/j.1464-410X.2010.09459.x
PMID:20575982
Abstract

OBJECTIVES

To investigate a possible association between the severity of lower urinary tract symptoms (LUTS) and the serum levels of sex hormones in men with symptomatic benign prostatic hyperplasia (BPH) that underwent surgery for severe benign prostatic obstruction.

PATIENTS AND METHODS

In all, 127 selected men with symptomatic BPH attending our urology clinic were recruited. The clinical conditions of BPH were assessed by digital rectal examination, serum prostate-specific antigen (PSA) determination, International Prostate Symptom Score (IPSS), transrectal ultrasonography and maximum urinary flow rate (Q(max) ) value at uroflussimetry. Before surgery, we measured the serum concentrations of total testosterone (TT) and free testosterone (FT), oestradiol, prolactin, luteinizing hormone and follicle-stimulating hormone. We excluded men with endocrine diseases, those with prostate disease who were receiving antiandrogen therapy and those with psychological diseases. The relationships between the IPSS score and serum sex hormone levels were determined.

RESULTS

The final study population consisted of 122 men (mean age of 70.66 years), as five were excluded (three due to incomplete evaluation and two who were diagnosed with prostate cancer). On statistical analysis, the total IPSS was significantly associated with age (r= 0.405, P < 0.001) and TT (r= 0.298, P= 0.020) but not with FT or the serum levels of the other sex hormones. The serum levels of testosterone and IPSS did not correlate with prostate volume and Q(max) . PSA level and age correlated with prostate volume (r= 0.394, P < 0.001; r = 0.374, P < 0.001, respectively). We distinguished two subgroups of patients: the first group of 40 men with an IPSS of <19 and the second group of 82 with an IPSS of >19, and we evaluated the median levels of TT in each group. There was an increased risk of LUTS in men with a greater serum concentration of TT (P= 0.042), although the mean TT level was in the normal range.

CONCLUSIONS

In the present study, the severity of LUTS was associated with age and serum levels of TT but only age correlated with the measures of BPH, especially prostate volume. The potential effects of testosterone on LUTS may well be indirect. Additional large studies are needed to confirm these preliminary results.

摘要

目的

研究经手术治疗严重良性前列腺增生(BPH)引起的良性前列腺梗阻的伴有症状的男性患者,其下尿路症状(LUTS)严重程度与血清性激素水平之间是否存在关联。

患者与方法

共纳入我院泌尿科就诊的 127 例有症状的 BPH 患者。通过直肠指检、血清前列腺特异抗原(PSA)测定、国际前列腺症状评分(IPSS)、经直肠超声和尿流率检查评估 BPH 的临床情况。在手术前,我们测量了总睾酮(TT)和游离睾酮(FT)、雌二醇、催乳素、黄体生成素和卵泡刺激素的血清浓度。我们排除了患有内分泌疾病、正在接受抗雄激素治疗的前列腺疾病患者和患有心理疾病的患者。确定了 IPSS 评分与血清性激素水平之间的关系。

结果

最终研究人群包括 122 名男性(平均年龄 70.66 岁),有 5 人被排除(由于评估不完整有 3 人,2 人被诊断为前列腺癌)。在统计学分析中,总 IPSS 与年龄(r=0.405,P<0.001)和 TT(r=0.298,P=0.020)显著相关,但与 FT 或其他性激素的血清水平无关。睾酮血清水平与 IPSS 与前列腺体积和 Qmax 不相关。PSA 水平和年龄与前列腺体积呈正相关(r=0.394,P<0.001;r=0.374,P<0.001)。我们将患者分为两组:第一组为 40 名 IPSS<19 的患者,第二组为 82 名 IPSS>19 的患者,并评估了每组的 TT 中位数水平。尽管 TT 的平均水平处于正常范围内,但血清 TT 浓度较高的男性发生 LUTS 的风险增加(P=0.042)。

结论

在本研究中,LUTS 的严重程度与年龄和 TT 血清水平相关,但只有年龄与 BPH 的指标相关,特别是前列腺体积。睾酮对 LUTS 的潜在影响可能是间接的。需要进一步的大型研究来证实这些初步结果。

相似文献

1
Relationship between lower urinary tract symptoms and serum levels of sex hormones in men with symptomatic benign prostatic hyperplasia.良性前列腺增生症患者下尿路症状与血清性激素水平的关系。
BJU Int. 2010 Dec;106(11):1700-3. doi: 10.1111/j.1464-410X.2010.09459.x.
2
Arteriosclerosis related factors had no clinical significant correlation with resistive index in symptomatic benign prostatic hyperplasia.动脉硬化相关因素与症状性良性前列腺增生的阻力指数无临床显著相关性。
Urology. 2011 Feb;77(2):433-7. doi: 10.1016/j.urology.2010.04.065. Epub 2010 Dec 18.
3
An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function.一项亚洲多国针对良性前列腺增生患者的前瞻性观察性登记研究,重点关注合并症、下尿路症状和性功能。
BJU Int. 2008 Jan;101(2):197-202. doi: 10.1111/j.1464-410X.2007.07320.x. Epub 2007 Nov 13.
4
Ejaculatory dysfunction in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.男性下尿路症状提示良性前列腺增生伴射精功能障碍。
BJU Int. 2009 Oct;104(7):974-83. doi: 10.1111/j.1464-410X.2009.08503.x. Epub 2009 May 7.
5
Association between erectile dysfunction and lower urinary tract symptoms due to benign prostatic hyperplasia in Nigerian men.尼日利亚男性勃起功能障碍与良性前列腺增生所致下尿路症状之间的关联。
Urol Int. 2008;80(3):296-9. doi: 10.1159/000127345. Epub 2008 May 14.
6
A 10-year follow-up after transurethral resection of the prostate, contact laser prostatectomy and electrovaporization in men with benign prostatic hyperplasia; long-term results of a randomized controlled trial.良性前列腺增生经尿道前列腺切除术、接触式激光前列腺切除术和电汽化术 10 年随访;一项随机对照试验的长期结果。
BJU Int. 2010 Sep;106(6):822-6. doi: 10.1111/j.1464-410X.2010.09229.x. Epub 2010 Feb 22.
7
Chronic kidney disease among men with lower urinary tract symptoms due to benign prostatic hyperplasia.良性前列腺增生导致下尿路症状的男性中的慢性肾脏病。
BJU Int. 2010 May;105(10):1424-8. doi: 10.1111/j.1464-410X.2009.08975.x. Epub 2009 Oct 28.
8
Serum sex hormones and the 20-year risk of lower urinary tract symptoms in community-dwelling older men.血清性激素与社区老年男性下尿路症状 20 年风险的关系。
BJU Int. 2010 Jun;105(11):1554-9. doi: 10.1111/j.1464-410X.2009.09090.x. Epub 2009 Dec 7.
9
Tadalafil relieves lower urinary tract symptoms secondary to benign prostatic hyperplasia.他达拉非可缓解良性前列腺增生继发的下尿路症状。
J Urol. 2007 Apr;177(4):1401-7. doi: 10.1016/j.juro.2006.11.037.
10
Urodynamic effects of once daily tadalafil in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia: a randomized, placebo controlled 12-week clinical trial.每日一次他达拉非治疗临床良性前列腺增生症下尿路症状患者的尿动力学效果:一项随机、安慰剂对照的 12 周临床试验。
J Urol. 2010 Mar;183(3):1092-7. doi: 10.1016/j.juro.2009.11.014. Epub 2010 Jan 25.

引用本文的文献

1
Risk Factors of Diabetic Bladder Dysfunction in Patients with Type 2 Diabetes Mellitus: A Case-Control Study in Shenzhen, China.2型糖尿病患者糖尿病膀胱功能障碍的危险因素:中国深圳的一项病例对照研究
Int Urogynecol J. 2025 Aug 23. doi: 10.1007/s00192-025-06282-z.
2
Screening tool for sarcopenia (SARC-F) predicts unsatisfactory medical treatment of lower urinary tract symptoms in elderly men aged 75 years or older: a preliminary observational study.肌肉减少症筛查工具(SARC-F)可预测75岁及以上老年男性下尿路症状的治疗效果不佳:一项初步观察性研究。
Int Urol Nephrol. 2025 Feb;57(2):399-406. doi: 10.1007/s11255-024-04233-z. Epub 2024 Oct 17.
3
Correlation Analysis between Hypogonadal Symptoms and Changes in Body Composition and Physical Fitness after Testosterone Treatment in Men with Testosterone Deficiency.
睾酮缺乏男性睾酮治疗后性腺功能减退症状与身体成分及体能变化的相关性分析
World J Mens Health. 2024 Jan;42(1):178-187. doi: 10.5534/wjmh.220274. Epub 2023 Apr 19.
4
Serum prostate specific antigen is a good indicator of prostatic volume in men with benign prostatic hyperplasia.血清前列腺特异性抗原是良性前列腺增生男性前列腺体积的良好指标。
Afr J Prim Health Care Fam Med. 2022 Dec 15;14(1):e1-e6. doi: 10.4102/phcfm.v14i1.3736.
5
Testosterone Replacement Therapy in the Aged Male: Monitoring Patients' Quality of Life Utilizing Scoring Systems.老年男性的睾酮替代疗法:利用评分系统监测患者的生活质量
Int J Gen Med. 2022 Sep 7;15:7123-7130. doi: 10.2147/IJGM.S253183. eCollection 2022.
6
Correlation Between Testosterone Replacement Treatment and Lower Urinary Tract Symptoms.睾酮替代治疗与下尿路症状之间的相关性
Int Neurourol J. 2021 Mar;25(1):12-22. doi: 10.5213/inj.2040234.117. Epub 2021 Jan 19.
7
Factors Associated with Bothersome Lower Urinary Tract Symptoms in Middle-Aged Men Receiving Health Checkup.与接受健康检查的中年男性烦人的下尿路症状相关的因素。
Sci Rep. 2019 Jan 29;9(1):901. doi: 10.1038/s41598-018-37605-4.
8
Comparison between selected hormone and protein levels in serum and prostate tissue homogenates in men with benign prostatic hyperplasia and metabolic disorders.比较良性前列腺增生和代谢紊乱男性患者血清和前列腺组织匀浆中选定激素和蛋白质水平。
Clin Interv Aging. 2018 Aug 3;13:1375-1382. doi: 10.2147/CIA.S168146. eCollection 2018.
9
Impact of Testosterone Deficiency and Testosterone Therapy on Lower Urinary Tract Symptoms in Men with Metabolic Syndrome.睾酮缺乏及睾酮治疗对代谢综合征男性下尿路症状的影响
World J Mens Health. 2018 Sep;36(3):199-222. doi: 10.5534/wjmh.180032. Epub 2018 Jul 3.
10
Prevalence and risk factors for erectile dysfunction and lower urinary tract symptoms in Russian Federation men: analysis from a national population-based multicenter study.俄罗斯男性勃起功能障碍和下尿路症状的患病率及危险因素:一项基于全国人口的多中心研究分析
Int J Impot Res. 2016 Mar-Apr;28(2):74-9. doi: 10.1038/ijir.2016.8. Epub 2016 Feb 11.